CONTRAST DIAGNOSTICS EPSILON LTD
Company number 13910231 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
CONTRAST DIAGNOSTICS EPSILON LTD - Analysis Report
Company Number: 13910231
Analysis Date: 2025-07-20 13:52 UTC
Risk Rating: HIGH
The company has minimal financial activity and assets, no recorded revenues or employees, and shows a dormant status per its accounts. The very limited asset base (£1,000) and absence of operational data indicate a high risk that it cannot meet obligations or sustain operations.Key Concerns:
- Minimal assets and shareholder funds (£1,000), indicating very limited financial capacity.
- Dormant status reported in accounts suggests no trading or income, raising liquidity and operational viability concerns.
- Single director and sole shareholder control may present governance risk if oversight or strategic direction is limited.
- Positive Indicators:
- Compliance with filing deadlines and no overdue accounts or confirmation statements, indicating regulatory adherence to date.
- Director’s acknowledgement of responsibilities and engagement of an accounting firm for preparation of statutory accounts.
- Company is active and not in liquidation, administration or receivership.
- Due Diligence Notes:
- Confirm actual trading activity and revenue generation plans given the dormant accounting status for multiple years.
- Investigate the nature and collectability of the £1,000 debtor balance.
- Understand the director’s longer-term intentions and any capital or operational plans to support business viability.
- Review any related party transactions given sole control by one individual.
- Verify whether the company’s SIC code (specialists medical practice) aligns with any actual business activities or assets.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.